Mixing insulin analogs for Type 1 kids is safe, say researchers

We’re usually told it’s a big health and safety no-no to mix ‘n’ match medications, right? Well, here’s an exception that affects diabetics. Apparently, youngsters with Type 1 diabetes and their parents/caregivers can safely mix rapid-acting and long-acting insulin analogs in the same syringe. The results of a new study published in the Journal of Pediatrics (April 2006) show that doing so does not compromise blood sugar stability in the long-term.

Examples of rapid-acting insulin analogues are Apridra and NovoRapid. Lantus is an examples of a long-acting insulin glargine. For some kids, mixing the two together could potentially reduce the number of insulin shots required daily. This is always good news for children and their parents.

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar   Joslin researchers find drugs are effective for diabetic macular edema in new trial   New superfoods could help key protein keep bodies healthy   Poor quality of life may affect teens’ diabetes management   Cancer drug protects against diabetes   Amino acid’s increase is suspected in diabetes   New Type 2 Diabetes Drug Onglyza Approved   Mail order pharmacy use safe for people with diabetes   Policy considerations pose options for leaders to reduce costly disparities in diabetes   Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery   Obesity-Linked Diabetes in Children Resists Treatment   Diabetes again linked to colon cancer risk